← FDA Drug Approvals (Drugs@FDA)
DICLOFENAC POTASSIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: UMEDICA · Approved 2022-05-11
Drug application
- FDA Application #
ANDA215750- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DICLOFENAC POTASSIUM
- Generic name
- DICLOFENAC POTASSIUM TABLETS
- Active ingredients
- DICLOFENAC POTASSIUM
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- UMEDICA
- Manufacturer
- Umedica Laboratories USA Inc.
- First approval
- 2022-05-11
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown